STK33 participates to HSP90-supported angiogenic program in hypoxic tumors by regulating HIF-1α/VEGF signaling pathway

Lately, the HSP90 client serine/threonine kinase STK33 emerged to be required by cancer cells for their viability and proliferation. However, its mechanistic contribution to carcinogenesis is not clearly understood. Here we report that elevated STK33 expression correlates with advanced stages of hum...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Yang, Steinestel, Konrad, Rouhi, Arefeh, Armacki, Milena, Diepold, Kristina, Chiosis, Gabriela, Simmet, Thomas, Seufferlein, Thomas, Azoitei, Ninel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5652794/
https://www.ncbi.nlm.nih.gov/pubmed/29100402
http://dx.doi.org/10.18632/oncotarget.20535

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5652794/
https://www.ncbi.nlm.nih.gov/pubmed/29100402
http://dx.doi.org/10.18632/oncotarget.20535

Ejemplares similares